CSIMarket
 
Alnylam Pharmaceuticals Inc   (ALNY)
 

Exceptional 29.59%, improvement in Revenues by the company during the financial time-frame ending December 31 2022

ALNY announced fourth quarter of 2022 operating deficit of $-188.614 million


Published Mar 26 2023
CSIMarket Team / CSIMarket.com


pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_CommonsFor the fourth quarter of 2022 company decreased a loss per share of $-1.64 per share compare to $-2.16 a year prior and earnings per share improved from $-3.32 per share from the prior financial reporting period.

Revenues increased rapidly by 29.59 % to $335.04 millions from $258.54 millions in the similar financial reporting period a year prior and sequentially Revenues improved by 26.76 % from $264.31 millions.




In the fourth quarter of 2022 Alnylam Pharmaceuticals Inc reported net loss of $-207.493 million, instead of deficit of $-258.460 millions in the similar financial reporting period a year ago.

ALNY announced loss of $-1,131.16 millions and Revenues of $1.04 billions in the financial year 2022.

Net loss per share has widen to $-9.30 from $-7.20 in prior financial year, while Revenues improved by 22.88 % from $844.29 millions a year prior.

Alnylam Pharmaceuticals Inc is expected to report next financial results on April 27, 2023.



Alnylam Pharmaceuticals Inc's Net Profit Margin

Alnylam Pharmaceuticals Inc's ROI



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com